We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Centers for Disease Control and Prevention (CDC) will evaluate Novavax’s pandemic influenza vaccine, including conducting pre-clinical tests on a live strain of H5N1 bird flu virus, the company said.